Cancer Genetics modifies TOO test

Create PDF

July 2018—Cancer Genetics announced it has received special 510(k) clearance from the FDA for its Tissue of Origin test following modifications made to test reagents and software. Compared with the earlier version, the current TOO assay uses new labeling reagents and has a higher accuracy rate and a shorter workflow.